News articles

News article list

• First licensed treatment for ultra-rare immune disorder recommended

  Leniolisib is the first ever treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) licensed for use in the NHS in England.

• First daily pill for endometriosis approved for NHS use

  Today we've recommended the first long-term daily pill to treat endometriosis that could transform how this painful condition is managed.

• Second consultation launched on NHS funding for Alzheimer's treatments

  Cost and evidence gaps remain barriers to approving funding in the NHS for donanemab and lecanemab.

• New drug approved for inherited clotting disorder, offering simpler dosing and enhanced quality of life.

  NICE publishes final draft guidance recommending efanesoctocog alfa as an option for treating and preventing bleeding in people aged 2 and over with severe haemophilia A.

• New option for adult leukaemia patients as we recommend treatment

  Today we've recommended an immunotherapy treatment that could prevent blood cancer from returning in adults who've responded well to initial therapy.